American International Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-32,200
| Closed | -$86K | – | 3128 |
|
|
2022
Q1 | $86K | Sell |
32,200
-2,267
| -7% | -$6.06K | ﹤0.01% | 2646 |
|
|
2021
Q4 | $149K | Sell |
34,467
-1,031
| -3% | -$4.46K | ﹤0.01% | 2533 |
|
|
2021
Q3 | $181K | Sell |
35,498
-844
| -2% | -$4.3K | ﹤0.01% | 2486 |
|
|
2021
Q2 | $230 | Buy |
36,342
+443
| +1% | +$3 | ﹤0.01% | 2417 |
|
|
2021
Q1 | $277 | Buy |
35,899
+9,655
| +37% | +$74 | ﹤0.01% | 2189 |
|
|
2020
Q4 | $172 | Sell |
26,244
-752
| -3% | -$5 | ﹤0.01% | 2360 |
|
|
2020
Q3 | $180K | Sell |
26,996
-615
| -2% | -$4.1K | ﹤0.01% | 2196 |
|
|
2020
Q2 | $230K | Buy |
27,611
+957
| +4% | +$7.97K | ﹤0.01% | 2046 |
|
|
2020
Q1 | $204K | Sell |
26,654
-1,541
| -5% | -$11.8K | ﹤0.01% | 1890 |
|
|
2019
Q4 | $234K | Sell |
28,195
-238
| -0.8% | -$1.98K | ﹤0.01% | 2122 |
|
|
2019
Q3 | $210K | Sell |
28,433
-198
| -0.7% | -$1.46K | ﹤0.01% | 2135 |
|
|
2019
Q2 | $321K | Buy |
28,631
+248
| +0.9% | +$2.78K | ﹤0.01% | 1956 |
|
|
2019
Q1 | $305K | Sell |
28,383
-920
| -3% | -$9.89K | ﹤0.01% | 1979 |
|
|
2018
Q4 | $442K | Sell |
29,303
-226
| -0.8% | -$3.41K | ﹤0.01% | 1748 |
|
|
2018
Q3 | $546K | Buy |
29,529
+4,407
| +18% | +$81.5K | ﹤0.01% | 1839 |
|
|
2018
Q2 | $574K | Buy |
25,122
+6,551
| +35% | +$150K | ﹤0.01% | 1739 |
|
|
2018
Q1 | $528K | Sell |
18,571
-998
| -5% | -$28.4K | ﹤0.01% | 1683 |
|
|
2017
Q4 | $413K | Buy |
19,569
+92
| +0.5% | +$1.94K | ﹤0.01% | 1898 |
|
|
2017
Q3 | $354K | Buy |
19,477
+1,456
| +8% | +$26.5K | ﹤0.01% | 1960 |
|
|
2017
Q2 | $279K | Buy |
18,021
+5,441
| +43% | +$84.2K | ﹤0.01% | 2078 |
|
|
2017
Q1 | $217K | Buy |
12,580
+834
| +7% | +$14.4K | ﹤0.01% | 2131 |
|
|
2016
Q4 | $129K | Sell |
11,746
-31
| -0.3% | -$340 | ﹤0.01% | 2451 |
|
|
2016
Q3 | $185K | Buy |
11,777
+18
| +0.2% | +$282 | ﹤0.01% | 2224 |
|
|
2016
Q2 | $120K | Buy |
11,759
+7,333
| +166% | +$74.9K | ﹤0.01% | 2474 |
|
|
2016
Q1 | $57K | Buy |
+4,426
| New | +$57K | ﹤0.01% | 3801 |
|